Robert Willoughby analyst CREDIT SUISSE

Currently out of the existing stock ratings of Robert Willoughby, 23 are a BUY (58.97%), 14 are a HOLD (35.9%), 2 are a SELL (5.13%).

Robert Willoughby

Work Performance Price Targets & Ratings Chart

Analyst Robert Willoughby works at CREDIT SUISSE with a stock forecast success ratio of 53.81% fulfilled within 143.29 days on average. Previously, Robert Willoughby worked at BAML.

Robert Willoughby’s has documented 94 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVS, CVS Health Corp at 08-Aug-2022.

Wall Street Analyst Robert Willoughby

Analyst best performing recommendations are on DPLO (DIPLOMAT PHARMACY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 4/28/2017. The price target of $140 was fulfilled within 6 days with a profit of $5.38 (4%) receiving and performance score of 6.66.

Average potential price target upside

ALGN Align Technology CVS CVS Health Corp WBA Walgreens Boots Alliance DPLO Diplomat Pharmacy MCK McKesson PDCO Patterson Companies RAD Rite Aid

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

335

$32.61 (10.78%)

290

1 months ago

14/26 (53.85%)

$61.62 (22.54%)

93

Hold

260

$-42.39 (-14.02%)

200

1 months ago

7/13 (53.85%)

$-4.74 (-1.79%)

146

Buy

310

$7.61 (2.52%)

260

1 months 11 days ago

21/27 (77.78%)

$43.66 (16.39%)

97

Hold

234

$-68.39 (-22.62%)

393

4 months 3 days ago

9/10 (90%)

$43.06 (22.55%)

217

Buy

250

$-52.39 (-17.33%)

430

4 months 4 days ago

27/34 (79.41%)

$59.44 (31.19%)

149

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Robert Willoughby?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?